SKL27969 / SK Bio 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
SKL27969 / SK Bio
NCT05388435: Safety, Tolerability, PK/PD & Preliminary Efficacy of SKL27969 in Advanced Solid Tumors Patients

Terminated
1/2
17
US
SKL27969
SK Life Science, Inc.
Advanced Solid Tumor
03/24
03/24

Download Options